Skip to main content
Article
Reduced Right Ventricular Ejection Fraction and Increased Mortality in Chronic Systolic Heart Failure Patients Receiving Beta-Blockers: Insights From the BEST Trial
International Journal Of Cardiology
  • Ravi V Desai, MD, Lehigh Valley Health Network
  • Jason L Guichard, MD, PhD, University of Alabama - Birmingham
  • Marjan Mujib, MD, MPH, University of Alabama - Birmingham
  • Mustafa I Ahmed, MD, University of Alabama - Birmingham
  • Margaret A Feller, MPH, University of Alabama - Birmingham
  • Gregg C Fonarow, MD, University of California - Los Angeles
  • Philippe Meyer, University Hospital of Geneva - Switzerland
  • Ami E Iskandrian, MD, University of Alabama - Birmingham
  • Herman J Bogaard, MD, Virginia Commonwealth University
  • Michel White, MD, Montreal Heart Institute
  • Inmaculada B Aban, PhD, University of Alabama - Birmingham
  • Wilbert S Aronow, MD, New York Medical College
  • Prakash Deedwania, MD, University of California - San Francisco
  • Finn Waagstein, MD, Sahlgrenska University Hospital - Sweden
  • Ali Ahmed, MD, MPH, University of Alabama - Birmingham
Publication/Presentation Date
2-10-2013
PubMedID
21704392
Document Type
Article
Citation Information

Desai, R., Guichard, J., Mujib, M., Ahmed, M., Feller, M., Fonarow, G., & ... Ahmed, A. (2013). Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving beta-blockers: insights from the BEST trial. International Journal Of Cardiology, 163(1), 61-67. doi:10.1016/j.ijcard.2011.05.051